BaylyTCKisnerDLSybertAMacDonaldJSTsouEScheinPS. Tetracycline and quinacrine in the control of malignant pleural effusions: A randomized trial. Cancer1978; 41: 1188–92.
2.
McNichollIHartLL. Mitoxantrone in pleural effusions. Ann Pharmacother1993; 27: 895–6.
3.
HickmanJAJonesMC. Treatment of neoplastic pleural effusions with local instillations of quinacrine (mepacrine) hydrochloride. Thorax1970; 25: 226–9.
4.
FingarBL. Sclerosing agents used to control malignant pleural effusions. Hosp Pharm1992; 27: 622–8.
5.
KeffordRFWoodsRLFoxRMTattersallMHN. Intracavitary adriamycin nitrogen mustard and tetracycline in the control of malignant effusions. Med J Aust1980; 2: 447–8.
6.
MillarJWHunterAMHorneNW. Intrapleural immunotherapy for corynebacterium parvum in recurrent malignant pleural effusions. Thorax1979; 35: 856–8.
7.
AndersonCBPhilpottGWFergusonTB. The treatment of malignant pleural effusions. Cancer1974; 33: 916–22.
8.
HausheerFHYarbroJW. Diagnosis and treatment of malignant pleural effusion. Semin Oncol1985; 12: 54–75.
9.
TattersallMHNBoyerMJ. Management of malignant pleural effusions (editorial). Thorax1990; 45: 81–2.
10.
RobinsonLAFlemingWHGalbraithTA. Intrapleural doxycycline control of malignant pleural effusions. Ann Thorac Surg1993; 55: 1115–22.
11.
KitamuraSSugiyamaYIzumiTHayashiRKosakaK. Intrapleural doxycycline for control of malignant pleural effusion. Curr Ther Res1981; 30: 515–21.
12.
ManssonT. Treatment of malignant pleural effusion with doxycycline. Scand J Infect Dis1988; 53 (suppl):29–34.
13.
RuckdeschelJCMooresDLeeJEinhornLMandelbaumIKoellerJIntrapleural therapy for malignant pleural effusions: A randomized comparison of bleomycin and tetracycline. Chest1991; 100: 1528–35.
14.
PaladineWCunninghamTSponzoRDonavanMOlsonKHortonJ. Intracavitary bleomycin in the management of malignant effusions. Cancer1976; 38: 1903–78.
15.
BitranJDBrownCDesserRKozloffMShapiroCBillingsA. Intracavitary bleomycin for the control of malignant effusions. J Surg Oncol1981; 16: 273–7.
16.
OstrowskiMJ. An assessment of the long-term results of controlling the reaccumulation of malignant effusions using intracavitary bleomycin. Cancer1986; 57: 721–7.
17.
OstrowskiMJHalsallGM. Intracavitary bleomycin in the management of malignant effusions: A multicenter study. Cancer Treat Rep1982; 66: 1903–7.
18.
SiegelRDSchiffmanFJ. Systemic toxicity following intracavitary administration of bleomycin. Chest1990; 98: 507.
19.
DanielTMTribbleCGRodgersBM. Thoracoscopy and talc poudrage for pneumothoraces and effusions. Ann Thorac Surg1990; 50: 186–9.
20.
HamedHFentimanISChaudaryMARubensRD. Comparison of intracavitary bleomycin and talc for control of pleural effusions secondary to carcinoma of the breast. Br J Surg1989; 76: 1266–7.
21.
PassHI. Treatment of malignant pleural and pericardial effusions. In: DeVitaVTJrHellmanSRosenbergSA, eds. Cancer: Principles and practice of oncology. Philadelphia: JB Lippincott; 1989: 2317–27.
22.
AdlerRHSayekI. Treatment of malignant pleural effusions: A method using tube thoracostomy and talc. Ann Thorac Surg1976; 22: 8–15.
23.
BouchamaAChastreJGaudichetASolerPGilbertC. Acute pneumonitis with bilateral pleural effusion after talc pleurodesis. Chest1984; 86: 795–7.
24.
RinaldoJEOwensGRRogersRM. Adult respiratory distress syndrome following intrapleural instillation of talc. J Thorac Cardiovasc Surg1983; 85: 523–6.
